Coronary Stents Market By Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), By Biomaterial (Metallic biomaterials, Polymers biomaterials, Natural biomaterials), By End User (Hospitals, Ambulatory Surgical Centers, Other): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global coronary stents market was valued at $8,814.9 million in 2020 and is projected to reach $15,421.06 million by 2030, registering a CAGR of 6.0% from 2021 to 2030. Coronary stent is a small expandable tube, which is used for the treatment of narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated using these stents. These stents are also known as cardiac stents and comprise metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI). The factor that drives growth of coronary stents market include increase in incidence of CAD, rise in innovation in coronary stents, and surge in improved clinical outcomes, due to stenting. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity and improved insurance & reimbursement scenario supplement the global coronary stents market growth. Conversely, availability of alternative methods for coronary heart disease treatment and high cost of treatment associated with coronary stents hinder the growth of the market during forecast years. However, increase in adoption of coronary stents in developing countries is expected to offer lucrative growth opportunities for the market during the forecast period. The global coronary stents market is segmented on the basis of product, biomaterial, end user, and region. Depending on product, it is classified into drug-eluting stent, bare-metal stent, and bioabsorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. According to end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The key market players profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Becton Dickinson and Company, Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Elixir Medical Corporation.
Key Benefits For Stakeholders ?This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary stents market analysis from 2020 to 2030 to identify the prevailing coronary stents market opportunities. ?The market research is offered along with information related to key drivers, restraints, and opportunities. ?Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network. ?In-depth analysis of the coronary stents market segmentation assists to determine the prevailing market opportunities. ?Major countries in each region are mapped according to their revenue contribution to the global market. ?Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players. ?The report includes the analysis of the regional as well as global coronary stents market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type ? Drug-eluting Stents ? Bare-metal Coronary Stents ? Bioabsorbable Stents
By End User ? Hospitals ? Ambulatory Surgical Centers ? Other
By Region ? North America ? U.S. ? Canada ? Mexico ? Europe ? Germany ? France ? U.K. ? Italy ? Spain ? Rest of LAMEA ? Asia-Pacific ? China ? Japan ? India ? Australia ? South Korea ? Rest of LAMEA ? LAMEA ? Brazil ? Saudi Arabia ? South Africa ? Rest of LAMEA ? Key Market Players ? Abbott Laboratories ? B. Braun Melsungen AG ? Biotronik Se & Co. KG ? Boston Scientific Corporation ? Becton, Dickinson and Company ? Elixir Medical Corporation ? Medtronic PLC. ? Microport Scientific Corporation ? Biosensors International Group ? Terumo Corporation
Our reports have been used by over 10K customers, including:
The Coronary Stent Market was Valued at USD 6,671.90 million in 2021, and it is expected to reach USD 8,358.38 million by 2027, registering a CAGR of 3.97 % during the forecast period. The COVID-19 pandemic has had ramifications for ways of working of surgical procedures due to the high rate of infection and lockdown restrictions; a...
“Coronary Stents–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding...
The global fractional flow reserve market is expected to grow at a CAGR of 12% during 2022-2027 The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing...
Report Scope: This report aims to provide a comprehensive study of the global market for stents, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding...
Standard Balloon Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update Summary Medical Devices sector report, “Standard Balloon Catheters Pipeline Report including Stages of Development, Segments, Region and Countries,...
250 pages •
By The Business Research Company
• May 2022
Major companies in the cardiovascular devices market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc., and Becton Dickinson. The global cardiovascular devices market is expected to grow from $53.44...
200 pages •
By The Business Research Company
• May 2022
Major players in the cardiac assist devices and equipment market are Abbot Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt Ltd., Calon Cardio - Technology Ltd., Cardiobridge GmbH, Balton Sp. Z O.O, Cardiac Assist Inc., Braile Biomedica Ltd., and circulate Inc. The global cardiac assist devices and equipment market is expected...
The cardiovascular devices market is expected to grow from US$ 48,106.47 million in 2021 to US$ 76,526.68 million in 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. The growth of the market is due to the increasing prevalence of cardiovascular diseases and the rising number of product launches & approvals. However, the high...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Annuloplasty Rings Market 2022-2026 The analyst has been monitoring the annuloplasty rings market and it is poised to grow by $ 31.19 mn during 2022-2026, accelerating at a CAGR of 3.5% during the forecast period. Our report on the annuloplasty rings market provides a holistic analysis, market size and forecast,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.